Home/Filings/4/0001567619-20-020622
4//SEC Filing

Beigelman Leonid 4

Accession 0001567619-20-020622

CIK 0001799448other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 8:03 PM ET

Size

5.6 KB

Accession

0001567619-20-020622

Insider Transaction Report

Form 4
Period: 2020-12-01
Beigelman Leonid
DirectorPresident
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-01+300,000300,000 total
    Exercise: $16.18Exp: 2030-12-01Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from December 1, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1
  • filerCIK 0001824721

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:03 PM ET
Size
5.6 KB